Please provide your email address to receive an email when new articles are posted on . Researchers analyzed more than 5,800 individuals with MS treated with fumarates for change in annual relapse ...
—A large international team of experts examined relapse activity and disability progression among pregnant and nonpregnant women of reproductive age with moderate-to-severe multiple sclerosis (MS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results